Science Explorer Back to mapMap
Discussion
Company · Hørsholm · Denmark

ExpreS2ion Biotechnologies (Denmark)

expres2ionbio.comROR OpenAlex
Research works
14
▲ 264% vs 2018-21
Citations
526
36.5 per fractional work
Top-10% rate
7.7%
all institutions 10.0%
Open access
80%
world 40%
International
66%
world 18%
ExpreS2ion Biotechnologies (Denmark)

Not ranked overall: ExpreS2ion Biotechnologies (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ExpreS2ion Biotechnologies (Denmark) work in?

In all years, 62% of research at ExpreS2ion Biotechnologies (Denmark) is in Life Sciences, 38% in Health Sciences. Its largest fields are Medicine (38%), Biochemistry, Genetics and Molecular Biology (34%), Immunology and Microbiology (23%). It does 2.3× the world's share of Life Sciences.

Life Sciences: 9 fractional works · 61.8% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 33.7% of its workMolecular Biology: 5 fractional works · 31.9% of its workBiotechnology: 0 fractional works · 1.9% of its workImmunology and Microbiology: 3 fractional works · 23.2% of its workImmunology: 3 fractional works · 18.3% of its workMicrobiology: 0 fractional works · 2.3% of its workParasitology: 0 fractional works · 1.6% of its workVirology: 0 fractional works · 1.2% of its workAgricultural and Biological Sciences: 1 fractional works · 4.9% of its workPlant Science: 0 fractional works · 2.3% of its workInsect Science: 0 fractional works · 1.6% of its workAnimal Science and Zoology: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 6 fractional works · 38.2% of its workMedicine: 6 fractional works · 38.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 9.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 7.4% of its workInfectious Diseases: 1 fractional works · 7.3% of its workOncology: 1 fractional works · 6.2% of its workEpidemiology: 1 fractional works · 4.4% of its workNeurology: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.7% of its workHepatology: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workALL ITS WORKExpreS2ionBiotechnologies…14fractional works, all years
Life Sciences62%Health Sciences38%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology533.7%
    2. Immunology and Microbiology323.2%
    3. Agricultural and Biological Sciences14.9%
    1. Medicine638.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at ExpreS2ion Biotechnologies (Denmark)?

Ranked on the quality score, Willem Adriaan de Jongh, Max Søgaard and Stine B. Clemmensen lead among researchers whose main affiliation is ExpreS2ion Biotechnologies (Denmark).

  1. 1 Willem Adriaan de Jongh Denmark · #219,849 worldwide 2.4k citations · 39 works
  2. 2 Max Søgaard Denmark · #691,774 worldwide 1.3k citations · 26 works
  3. 3 Stine B. Clemmensen Denmark · #823,661 worldwide 982 citations · 28 works
All ranked researchers at ExpreS2ion Biotechnologies (Denmark)

What are the most cited papers from ExpreS2ion Biotechnologies (Denmark)?

The most cited paper from ExpreS2ion Biotechnologies (Denmark) is "Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies" (Katherine E. Wright, Kathryn A. Hjerrild, Jonathan D. Bartlett et al., 2014), with 243 citations. Next come "Bacterial superglue enables easy development of efficient virus-like particle based vaccines" (215) and "Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies" (176).

Most cited papers
#PaperReleasedCitations
1 Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies Katherine E. Wright, Kathryn A. Hjerrild, Jonathan D. Bartlett et al. · Nature Open access 15 Aug 2014 243
2 Bacterial superglue enables easy development of efficient virus-like particle based vaccines Susan Thrane, Christoph Mikkel Janitzek, Sungwa Matondo et al. · Journal of Nanobiotechnology Open access 18 Apr 2016 215
3 Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies Daniel G. W. Alanine et al. · Cell Open access Jun 2019 176
4 Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination Angela M. Minassian et al. · Med Open access 20 Apr 2021 170
5 First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria Benjamin G. Mordmüller et al. · Clinical Infectious Diseases Open access 3 Jan 2019 161
All 51 most cited papers, with filters and sorting

Which research topics does ExpreS2ion Biotechnologies (Denmark) publish most on?

By volume in 2022-now: Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, Monoclonal and Polyclonal Antibodies Research and Cancer Immunotherapy and Biomarkers.

Immunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksvaccines and immunoinfor…1vaccines and immunoinformatics approaches: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksBacterial Infections and Vaccines: 0 fractional worksViral Infections and Vectors: 0 fractional worksVector-borne infectious diseases: 0 fractional works
ImmunologyMolecular BiologyRadiology, Nuclear Medicine and ImagingOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 2 works
  2. 2 vaccines and immunoinformatics approaches Molecular Biology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  6. 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  7. 7 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  8. 8 Bacterial Infections and Vaccines Microbiology 0 works
  9. 9 Viral Infections and Vectors Infectious Diseases 0 works
  10. 10 Vector-borne infectious diseases Parasitology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available80.2%not open19.8%

World: 40% of research is openly available.

with international co-authors65.9%domestic only34.1%

World: 18% is written across borders.

How has ExpreS2ion Biotechnologies (Denmark)'s research output changed?

Output in 2022-2025 was 264% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ExpreS2ion Biotechnologies (Denmark) as a percentage of every work published that year, 0.000041% in 2024.

still counting0.000025%0.000050%0.000075%ExpreS2ion Biotechnologies (Denmark)0.000011% in 202520102020

Fractional works of ExpreS2ion Biotechnologies (Denmark) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hørsholm

All research institutions in Hørsholm

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ExpreS2ion Biotechnologies (Denmark). Posts are plain text and can be reported.